Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to ...

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

Palo Alto Networks (NASDAQ: PANW) investors just cannot catch a break. Over the past three days, this cybersecurity stock has ...

Vuzix Corp (VUZI) stock saw a modest uptick, ending the day at $4.22 which represents a slight increase of $0.11 or 2.68% from the prior close of $4.11. The stock opened at $4.08 and touched a low of ...

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...

BofA Securities has recently resumed On Holding AG (ONON) stock to Buy rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 18, 2024, Citigroup had initiated the stock to ...

Energy is the star sector of the S&P 500 index in the early days of 2025, shaking off two consecutive years when it was a market laggard, and gaining despite Wall Street’s dim outlook for oil and gas ...

Analyst Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report) and keeping the price ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Real-time index price for TSX American Preferred Stock Index (STNC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...